Back to search
Dementia Severe
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Dementia Severe trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Dementia Severe trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
An open-label, exploratory, phase II, proof-of concept, clinical study to assess the safety and tolerability of EI-1071 and the effects of EI-1071 on neuroinfla…
This study will examine the biological factors that may modulate the relationship between depression and the development of Alzheimer's disease (AD). Since the…
DAN-ZOSTER is a nationwide randomized study investigating whether vaccination against herpes zoster (shingles) can reduce the risk of cardiovascular disease and…
This study will explore the effect of ECT treatments plus usual care (ECT+UC) in reducing severe agitation in patients with moderate to severe dementia includin…
The goal of this clinical trial is to learn if propranolol can help reduce challenging behaviors associated with Autism Spectrum Disorder, including aggression,…
Using a 2-arm, RCT approach, the primary goal of the study is to evaluate the feasibility and preliminary efficacy of Inspiratory Muscle Strength Training (IMST…
Alzheimer's disease (AD) is a severe neurodegenerative disease with heavy social burden. Current drugs cannot reverse disease progression. Brain glymphatic syst…
Immediate family members shoulder the majority of care responsibilities for persons living with dementia. However, due to various societal changes, elder care r…